Cancer-Associated Transporters: Molecular Drivers and Drug Delivery Gateways

Strategic Insights -

Researchers at Amity University Uttar Pradesh have highlighted the critical role of membrane transporters in cancer, noting that their expression is frequently reprogrammed to support enhanced growth, survival, and therapy resistance. These transporters, regulated by the tumor suppressor p53, facilitate the uptake and efflux of nutrients, ions, and drugs, making them attractive therapeutic targets. The study emphasizes the need for personalized cancer therapy that takes into account the unique molecular characteristics of each patient's tumor.

Key Takeaways:

  • The study found that membrane transporters are critical regulators of cellular homeostasis, mediating the uptake and efflux of nutrients, ions, and drugs in cancer cells.
  • Among the solute carrier transporters, several have been identified as therapeutic targets, including glucose transporters (GLUTs), monocarboxylate transporters (MCTs), and the sodium/iodine symporter (NIS).
  • The tumor suppressor p53 regulates a broad spectrum of membrane transporters, but oncogenic mutations or structural conversion into amyloids can disrupt this regulatory network, leading to altered transporter expression and multidrug resistance.
  • The researchers propose that dual targeting of p53 aberrations and membrane transporters through synthetic biology and precision delivery approaches could restore chemosensitivity and suppress tumor progression.
  • This approach could offer promising avenues for personalized cancer therapy, which is a critical need in the field.
  • The researchers also highlight the potential of LAT1 inhibition to starve tumors of essential nutrients, demonstrating a therapeutic strategy aimed at modulating transporter function.
  • Additional authors for this research include Aqsa Khan, Manoj Garg, and Shinjinee Sengupta.

Statistics:

  • 242:117376 is the journal article identifier for the study, which was published in the journal Biochemical Pharmacology.
  • 117376 is the insert number for the article.
  • 2025 is the year the journal article was published.
  • Biochemical Pharmacology is the journal in which the study was published.

Sources:

  • Cancer-associated transporters: Molecular drivers and drug delivery gateways. Biochemical Pharmacology, 2025;242:117376.
  • Biochemical Pharmacology can be contacted at: Pergamon-elsevier Science Ltd, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, England.